HLB Inc
KOSDAQ:028300
HLB Inc
Cost of Revenue
HLB Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
HLB Inc
KOSDAQ:028300
|
Cost of Revenue
-₩43.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
SD Biosensor Inc
KRX:137310
|
Cost of Revenue
-₩529.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
EOFlow Co Ltd
KOSDAQ:294090
|
Cost of Revenue
-₩8.5B
|
CAGR 3-Years
-130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Cost of Revenue
-₩25.5B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Cost of Revenue
-₩47.4B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Cost of Revenue
-₩74B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-16%
|
See Also
What is HLB Inc's Cost of Revenue?
Cost of Revenue
-43.8B
KRW
Based on the financial report for Dec 31, 2023, HLB Inc's Cost of Revenue amounts to -43.8B KRW.
What is HLB Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
Over the last year, the Cost of Revenue growth was 61%. The average annual Cost of Revenue growth rates for HLB Inc have been 2% over the past three years , -8% over the past five years , and -9% over the past ten years .